Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice
Authors:
- 1 July 2014
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 735, 115-122
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare
This publication has 39 references indexed in Scilit:
- Activation of Colonic Mucosal 5-HT4 Receptors Accelerates Propulsive Motility and Inhibits Visceral HypersensitivityGastroenterology, 2012
- 5-HT2B receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunctionNeurogastroenterology & Motility, 2009
- Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in ratsBritish Journal of Pharmacology, 2009
- Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2008
- 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-α]pyridine-8-carboxamide (CJ-033,466), a Novel and Selective 5-Hydroxytryptamine4 Receptor Partial Agonist: Pharmacological Profile in Vitro and Gastroprokinetic Effect in Conscious DogsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI DisordersGastroenterology, 2007
- 5-HT induces duodenal mucosal bicarbonate secretion via cAMP- and Ca2+-dependent signaling pathways and 5-HT4 receptors in miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokineticsAlimentary Pharmacology & Therapeutics, 2004
- Long-term efficacy of oral cisapride in symptomatic upper gut dysmotilityDigestive Diseases and Sciences, 1991
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973